Table 6.
SEROGROUP O1 | ||
---|---|---|
No. | Resistance pattern | No. exhibiting resistance pattern (%) |
R1 * | TE R DXT R | 3 (25) |
R2 * | AML R TE R SXT R | 7 (58.3) |
R3 | AML R SXT R C R | 1 (8.3) |
R4 | AML R AUG R CR | 1 (8.3) |
Total | 12 (37.5) | |
SEROGROUP NON-O1/NON-O139 | ||
No. | Resistance pattern | No. exhibiting resistance pattern (%) |
R5 | AML R SXTR | 4 (11.8) |
R6 | AML R TE R | 1 (2.9) |
R7 | AUG R TE R | 1 (2.9) |
R8 | AML R AUG R | 1 (2.9) |
R9 * | TE R DXT R | 4 (11.8) |
R10 | TE R SXT R | 4 (11.8) |
R11 | TE R DXT R SXT R | 2 (5.9) |
R12 * | AML R TE R SXT R | 10 (29.4) |
R13 | AML R AUG R SXT R | 1 (2.9) |
R14 | AUG R TE R SXT R | 2 (5.9) |
R15 | AML R TE R DXT R SXT R | 2 (5.9) |
R16 | AML R TE R SXT R C R | 1 (2.9) |
R17 | AML R TE R DXT R SXT R C R | 1 (2.9) |
Total | 34 (53.1) |
AML, amoxicillin; AUG, augmentin; TE, tetracycline; DXT, doxycycline; SXT, trimethoprim/sulfamethoxazole; C, chloramphenicol; R, resistant; * resistance patterns detected in both Vibrio cholerae O1 and non-O1/non-O139 strains.